Name:Salazodimethoxin (Salazodimethoxintun)
Indications for use:
Non-specific ulcerative colitis (chronic inflammation of the colon with the formation of ulcers, caused by unclear reasons) in the active stage, mainly in mild and moderate forms of the disease, poor tolerance or ineffectiveness of salazopyridazine.
Pharmacological action:
Sulfanilamide of prolonged (long-term) action. – Like salazopyridazine, the product breaks down in the intestines, with the formation of 5-aminosalicylic acid and sulfadimethoxin, which have anti-inflammatory and antibacterial effects. The drug has low toxicity.
Salazodimethoxintun (Salazodimethoxin) method of administration and dose:
Assign inside (after eating) in approximately the same doses and for the same period as salazopyridazine. Usually given to adults 0.5 g 4 times every day (1 g 2 times every day) for 3-4 weeks, and then (if a therapeutic effect has occurred during this period) 0.5 g 2-3 times each day for the next 2-3 weeks. In severe forms of the disease, the daily dose is increased in the first days to 4 g, and after a decrease in the frequency of stools, the dose is reduced. In mild forms of the disease, you can start with a dose of 1.5 g per day, and if there is no effect, go to 2 g per day.
Children aged 3 to 5 years in the first 7-14 days are prescribed 0.5 g per day, in the next 2 weeks. – 0.25 g per day, on other days (until the 40th – 50th day from the start of treatment) – 0.125 g per day; children from 5 to 7 years old – respectively, 0.8-1.0 g each; 0.4-0.5 g and 0.2-0.25 g; from 7 to 15 years – 1.0-1.5 g; 0.5-0.75 g and 0.25-0.375 g. Daily doses are given in 2-3 doses.
If during the first 14 days from the start of treatment it is not possible to obtain a therapeutic effect, salazodimethoxine is canceled; you can switch to the use of salazopyridazine or salazosulfapyridine.
To prevent recurrence (reappearance of signs of the disease) of ulcerative colitis and Crohn’s disease (a disease of unknown cause, characterized by inflammation and narrowing of the lumen of individual sections of the intestine), salazodimethoxine is prescribed for a long time in gradually decreasing doses: for adults, 0.5 g 1-2 times every day every a day for 2-6 months, then 0.25-0.5 g every day or every other day for 6-12 months. For children, the product is prescribed in smaller doses, taking into account the age and doses used in the acute period of the disease. In case of deterioration of health, the dose of salazodimethoxine is increased.
Salazodimethoxintun (Salazodimethoxin) contraindications:
Increased susceptibility to sulfonamides.
Salazodimethoxintun (Salazodimethoxin) side effects:
Allergic reactions, leukopenia (decrease in the level of leukocytes in the blood), dyspeptic disorders (digestive disorders).
Release form:
Tablets of 0.5 g in a pack of 50 pcs.
Storage conditions:
List B. In a place protected from light.
Attention!
Before using the medication“Salazodimethoxintun (Salazodimethoxin)” should be consulted with a doctor.
The instructions are provided solely for familiarization with “Salazodimethoxintun (Salazodimethoxin) “.